Johnson & Johnson Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 16 of 340 Posts
1 2 3 ... 22
Week In Review: China Life Science Deals Total $550 Million
Article By: ChinaBio® Today Saturday, December 9, 2017 4:13 PM EST
Pfizer (NYSE: PFE​) signed a $226 million agreement for China/Asian rights to Cresemba® (isavuconazole), an antifungal drug and Everest Medicines announced a $224 million partnership with San Diego's Arena Pharma.
In this article: JNJ, GNBT, BYSI, BMY, ARNA, BABA, PFE
Pfizer/Merck KGaA Drug Fails In Study, Teva CEO Announces Changes
Article By: Arpita Dutt Friday, December 1, 2017 8:57 AM EST
While reports about tech giant Amazon meeting generic drugmakers made the rounds, companies like Pfizer and Teva Pharmaceutical Industries Ltd.’s were in the news with the former reporting late-stage data.
In this article: JNJ, PFE, MYL Also: BMY, GSK, TEVA, NVO
Investors Pummel Celgene
Article By: Shock Exchange Friday, October 27, 2017 8:39 PM EST
CELG fell over 15% after Q3 earnings Thursday. Weak guidance, slowing growth from Revlimid and questions over the pipeline spooked investors.
In this article: CELG, VRX, JNJ
An Investor Guide For When The Crash Is In Your Rear Mirror
Article By: The Dividend Guy Thursday, October 26, 2017 1:21 PM EST
Getting rid of weaker positions is not an exact science and you could make mistakes. There is no point of seeing all your stocks as potential losers, but taking off your pinky glasses may not hurt.
In this article: JNJ, MMM, PG
Baby DivHut Dividend Income Portfolio Update Q3 2017
Article By: Keith Park Monday, October 23, 2017 1:00 PM EST
With nine months of the year already behind us, I highlight baby DivHut’s quarterly dividend income/portfolio progress. With the stock market continuing to chug along it was nice to see some impressive gains made in the two-year-old portfolio.
Healthcare ETF (VHT) Hits New 52-Week High
Article By: Zacks Investment Research Friday, October 20, 2017 8:03 PM EST
Investors seeking momentum may have Vanguard Healthcare ETF on their radar now. The fund recently hit a new 52-week high. Shares of VHT are up approximately 29.2% from the 52-week low of $120.38/share.
In this article: JNJ, PFE, UNH, VHT
Are These The 6 Best Stocks In The Dow Jones Industrial Average? – Part 3
Video By: Chuck Carnevale Friday, October 13, 2017 4:47 PM EST
Successful long-term investors need to be willing to own stocks through the inevitable peaks and valleys that will come along the way.
In this video: JNJ, UTX, WMT, AAPL, DIS, UNH
Johnson & Johnson Upgraded To Outperform From Market Perform At Wells Fargo
Article By: The Fly Monday, October 9, 2017 9:13 AM EST
Wells Fargo analyst Larry Biegelsen upgraded Johnson & Johnson to Outperform and raised his price target for the shares to $149 from $140. The healthcare giant closed Friday up 1c to $133.22.
In this article: JNJ
Here's What's Has Happened In The HCV Space Lately
Article By: Zacks Investment Research Sunday, October 8, 2017 6:08 PM EST
It is not a surprise that quite a few pharma and biotech companies are working on bringing new, improved, shorter-duration hepatitis C virus (HCV) treatments to the market. The market is thus getting crowded and seeing increased pricing pressure.
In this article: JNJ, GILD, ABBV, MRK Also: BMY
Which Of These 5 Stocks Will Win This NFL Season?
Article By: TipRanks Monday, September 11, 2017 3:10 AM EST
In the last three months, Kraft Heinz shares have dropped $12 to $81 leaving analysts fairly evenly split between buy and hold ratings. KHC has seen lackluster trends and has also suffered from its failed attempt to buy Unilever for $115 billion.
In this article: F, JNJ, KHC, HD, MSFT
3 Excellent Dividend ETFs For Turbulent Times
Article By: Zacks Investment Research Sunday, September 10, 2017 6:50 PM EST
U.S. equity markets are going through turbulent times. There is a lot of volatility and uncertainty owing to rising geopolitical risks and political uncertainty. This has increased the appeal for dividend investing.
In this article: VIG, DGRW, DGRO, AAPL, MSFT, JNJ, PEP, PFE
10 Great Dividend Stocks To Own Now If The Rally Ends
Article By: SureDividend Friday, September 1, 2017 2:37 PM EST
The stock market has come a long way since the Great Recession, and could be nearing a top. If that’s the case, investors should position their portfolios defensively, and focus on high-quality dividend payers.
In this article: MT, MCD, JNJ, MO, ED, CHD, GIS, BF-B, DG, CPB Also: AMZN, BUD
EC JNJ Bulls Be Warned... An Elliot Wave Approach
Article By: Alexandros Yfantis Thursday, August 24, 2017 8:30 AM EST
Johnson & Johnson could be at the very early stages of a big decline as an impulse wave pattern since the lows of 2015 might be complete. Bulls need to be very cautious.
In this article: JNJ
Today Was The Big Solar Eclipse
Article By: Marvin R Clark Monday, August 21, 2017 11:41 PM EST
Since August 7, the Dow Industrials have given back 397 points or 1.7%. The S&P 500 has slipped 0.08%, and the technology-weighted Nasdaq has led the way lower with a 2.6% move.
In this article: JNJ, SRE, TOT, IWM, FCAU, BRK-A, BRK-B
51 Firms Going Ex-Dividend Next Week, Including Aflac, Southwest And Johnson & Johnson
Article By: Timothy J. McIntosh Saturday, August 19, 2017 6:40 PM EST
There are several well known large cap stocks going ex-dividend next week. Ex-dividend dates are important to dividend investors because one must own a stock on its ex-dividend date in order to be eligible to receive its next dividend.
In this article: AFL, DFS, JNJ, LUV
How Much Does The Volatility Of Individual Stocks Change Over Time?
Article By: SureDividend Tuesday, August 15, 2017 9:51 AM EST
Clorox’s low volatility is similar to that of Procter & Gamble: as a manufacturer, marketer, and distributor of household consumer products, Clorox’s sales tend to stand up well to periods of economic downturn.
In this article: CLX, AFL, BEN, FRT, NUE, TROW, SPY, JNJ, PEP, PG
1 to 16 of 340 Posts
1 2 3 ... 22